Technological innovations have revolutionized the treatment of type 1 diabetes. Although technological advances can potentially improve diabetes outcomes, maintenance of target glycemic control, at the present time, remains largely dependent on patient and family motivation, competence, and adherence to daily diabetes care requirements. Trials of closed loop or "artificial pancreas" technology show great promise to automate insulin delivery and achieve near normal glucose control and reduced hypoglycemia with minimal patient intervention.
CITATION STYLE
Garvey, K., & Wolfsdorf, J. I. (2015, August 1). The Impact of Technology on Current Diabetes Management. Pediatric Clinics of North America. W.B. Saunders. https://doi.org/10.1016/j.pcl.2015.04.005
Mendeley helps you to discover research relevant for your work.